De novo mass spectrometry peptide sequencing with a transformer model
Yilmaz, M.; Fondrie, W. E.; Bittremieux, W.; Oh, S.; Noble, W. S.
Show abstract
Tandem mass spectrometry is the only high-throughput method for analyzing the protein content of complex biological samples and is thus the primary technology driving the growth of the field of proteomics. A key outstanding challenge in this field involves identifying the sequence of amino acids--the peptide--responsible for generating each observed spectrum, without making use of prior knowledge in the form of a peptide sequence database. Although various machine learning methods have been developed to address this de novo sequencing problem, challenges that arise when modeling tandem mass spectra have led to complex models that combine multiple neural networks and post-processing steps. We propose a simple yet powerful method for de novo peptide sequencing, Casanovo, that uses a transformer framework to map directly from a sequence of observed peaks (a mass spectrum) to a sequence of amino acids (a peptide). Our experiments show that Casanovo achieves state-of-the-art performance on a benchmark dataset using a standard cross-species evaluation framework which involves testing with spectra with never-before-seen peptide labels. Casanovo not only achieves superior performance but does so at a fraction of the model complexity and inference time required by other methods.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Group-walk, a rigorous approach to group-wise false discovery rate analysis by target-decoy competition 96%
- Mistle: bringing spectral library predictions to metaproteomics with an efficient search index 95%
- TopNEXt: Automatic DDA Exclusion Framework for Multi-Sample Mass Spectrometry Experiments 95%
Similar papers in this journal
- Joint structural annotation of small molecules using liquid chromatography retention order and tandem mass spectrometry data 94%
- Evaluating generalizability of artificial intelligence models for molecular datasets 93%
- Personalized deep learning of individual immunopeptidomes to identify neoantigens for cancer vaccines 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.